{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:06:11Z","timestamp":1776161171111,"version":"3.50.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>We investigated the diagnostic challenges of TAFRO syndrome and idiopathic multicentric Castleman disease (iMCD), focusing on the usefulness of anterior mediastinal lesions for distinguishing the disease subtypes. A comparative analysis using computed tomography (CT) imaging was performed for three patient groups: TAFRO without iMCD\/iMCD-TAFRO (n=13), iMCD-idiopathic plasmacytic lymphadenopathy (IPL)- not otherwise specified (NOS) (n=16), and IgG4-related disease (IgG4-RD) (n=59). Lesions were categorized into increased fat density, micronodular opacity, and mass. The lesions\u2019 CT attenuation values were compared, and receiver operating characteristic (ROC) curve analyses assessed their diagnostic relevance. Anterior mediastinal lesions were most frequent in the TAFRO without iMCD\/iMCD-TAFRO group (85%) compared to the iMCD-IPL\/NOS group (31%) and IgG4-RD group (6.8%). Distinct patterns such as increased fat density were predominantly observed in the TAFRO without iMCD\/iMCD-TAFRO group. The CT values showed significant intergroup differences, with ROC analyses confirming high diagnostic accuracy for distinguishing the TAFRO without iMCD\/iMCD-TAFRO group from the other groups. Post-treatment, all patients with TAFRO without iMCD\/iMCD-TAFRO showed improvement in CT readings, whereas only half of the patients with iMCD-NOS group showed changes. These findings emphasize the importance of CT-detected anterior mediastinal lesions in the diagnosis of TAFRO without iMCD\/iMCD-TAFRO and warrant further research to validate these results.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1656489","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:29:20Z","timestamp":1757914160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Lamiaa","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Toya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Umetsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuna","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura","year":"2021","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04762-6","article-title":"Castleman disease and TAFRO syndrome","volume":"101","author":"Masaki","year":"2022","journal-title":"Ann Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810301","article-title":"Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric castleman disease","volume":"23","author":"Nishikori","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27743","article-title":"International consensus histopathological criteria for subtyping idiopathic multicentric castleman disease based on machine learning analysis","volume":"100","author":"Nishimura","year":"2025","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12185-020-03008-3","article-title":"Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan","volume":"113","author":"Fujimoto","year":"2021","journal-title":"Int J Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5850-20","article-title":"Complete resolution of a case of TAFRO syndrome accompanied by mediastinal panniculitis, adrenal lesion, and liver damage with hyperbilirubinemia","volume":"60","author":"Ono","year":"2021","journal-title":"Intern Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40792-016-0188-8","article-title":"A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgery","volume":"2","author":"Nagano","year":"2016","journal-title":"Surg Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.173","article-title":"An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy","volume":"4","author":"Sakashita","year":"2016","journal-title":"Respirol Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2016.10.003","article-title":"Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography","volume":"55","author":"Ozawa","year":"2017","journal-title":"Respir Investig"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2016160076","article-title":"Castleman disease of the thorax: clinical, radiologic, and pathologic correlation: from the radiologic pathology archives","volume":"36","author":"Kligerman","year":"2016","journal-title":"Radiographics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06919-1","article-title":"Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities","volume":"30","author":"Kurokawa","year":"2020","journal-title":"Eur Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2017.05.007","article-title":"CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman\u2019s disease","volume":"72","author":"Kiguchi","year":"2017","journal-title":"Clin Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.24053","article-title":"Computed tomography findings of idiopathic multicentric Castleman disease subtypes","volume":"64","author":"Iguchi","year":"2024","journal-title":"J Clin Exp Hematop"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2023-209280","article-title":"Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease","author":"Nishikori","year":"2024","journal-title":"J Clin Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02780-1","article-title":"2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome","volume":"111","author":"Masaki","year":"2020","journal-title":"Int J Hematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ajh.27612","article-title":"Exploring the clinical diversity of castleman disease and TAFRO syndrome: A Japanese multicenter study on lymph node distribution patterns","volume":"100","author":"Otsuka","year":"2025","journal-title":"Am J Hematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1366093","article-title":"Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan","volume":"28","author":"Fujimoto","year":"2018","journal-title":"Mod Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1656489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:29:21Z","timestamp":1757914161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1656489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2025.1656489"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1656489","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"1656489"}}